Company news

HLS Therapeutics, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

HLS Therapeutics Announces Updates to its Credit Agreement

August 14, 2023

HLS Therapeutics Announces Q2 Fiscal 2023 Financial Results

August 10, 2023

HLS Therapeutics to Host Q2 Fiscal 2023 Financial Results Conference Call

August 3, 2023

HLS Therapeutics Announces Updates to its Board of Directors

June 22, 2023

HLS Therapeutics Announces Agreement with Polar Asset Management Partners and Retirement of Two Directors from the Board of Directors

June 8, 2023

HLS Therapeutics Announces Q1 Fiscal 2023 Financial Results

May 11, 2023

HLS Therapeutics to Host Q1 Fiscal 2023 Financial Results Conference Call

May 3, 2023

HLS Therapeutics to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference

April 21, 2023

HLS Therapeutics Announces CEO Transition

April 17, 2023

HLS Therapeutics Announces Q4 and Fiscal 2022 Financial Results

March 16, 2023

HLS Therapeutics to Host Q4 and Fiscal 2022 Financial Results Conference Call

March 2, 2023

HLS Therapeutics Announces Board Appointment

November 29, 2022

HLS Therapeutics to Present at the Stifel Healthcare Conference

November 14, 2022

HLS Therapeutics Announces Q3 Fiscal 2022 Financial Results and Renewal of Normal Course Issuer Bid

November 10, 2022

HLS Therapeutics Highlights Key Data on the Late Breaking RESPECT-EPA Study Presented at the American Heart Association

November 7, 2022

HLS Therapeutics to Host Q3 Fiscal 2022 Financial Results Conference Call

October 27, 2022

HLS Therapeutics to Participate in Virtual Non-Deal Roadshow on September 22, 2022

September 15, 2022

HLS Therapeutics Announces Q2 Fiscal 2022 Financial Results

August 11, 2022

HLS announces that Vascepa® is now reimbursed by the Saskatchewan Drug Plan

August 2, 2022

HLS Therapeutics to Host Q2 Fiscal 2022 Financial Results Conference Call

July 28, 2022

HLS Announces that Vascepa® is now reimbursed by Ontario's Provincial Drug Plan

July 25, 2022

HLS Therapeutics Obtains Public Reimbursement for Vascepa® in New Brunswick and with other Public Payors

June 22, 2022

HLS Therapeutics to Participate in Virtual Non-Deal Roadshow on June 22, 2022

June 15, 2022

HLS Therapeutics to Present at the 2022 Jefferies Healthcare Conference

June 1, 2022

HLS Therapeutics Executive Chairman and Co-Founder Bill Wells to Retire

May 24, 2022

HLS Therapeutics Obtains Public Reimbursement for Vascepa® in Quebec

May 24, 2022

HLS Therapeutics Announces Q1 Fiscal 2022 Financial Results

May 5, 2022

HLS Therapeutics to Host Q1 Fiscal 2022 Financial Results Conference Call

April 28, 2022

HLS Therapeutics completes negotiations with pCPA for Vascepa®

April 26, 2022

HLS Therapeutics to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference

April 25, 2022

HLS Therapeutics Announces Q4 and Fiscal 2021 Financial Results

March 17, 2022

HLS Therapeutics to Host Q4 & Fiscal 2021 Financial Results Conference Call

March 14, 2022

HLS Therapeutics to Present at the Sidoti Investor Conference

January 12, 2022

HLS Therapeutics Establishes Automatic Share Purchase Plan

December 20, 2021

HLS Therapeutics to Present at Stifel GMP's Future of Healthcare Conference

December 1, 2021

HLS Therapeutics to Present at the Stifel 2021 Virtual Healthcare Conference

November 11, 2021

HLS Therapeutics Announces Q3 Fiscal 2021 Financial Results

November 4, 2021

HLS Therapeutics to Host Q3 2021 Financial Results Conference Call

October 21, 2021

HLS Therapeutics to Participate in Two Virtual Non-Deal Roadshows

October 4, 2021

HLS Therapeutics Announces Promotional Agreement with Pfizer for Vascepa® in Canada

August 16, 2021

HLS Therapeutics Announces Second Quarter Fiscal 2021 Financial Results

August 5, 2021

HLS Therapeutics to Present at the Canaccord Genuity 41st Annual Growth Conference

August 4, 2021

HLS Therapeutics to Host Q2 2021 Financial Results Conference Call

July 22, 2021

HLS Therapeutics to Participate in Virtual Non-Deal Roadshow on June 16, 2021

June 15, 2021

HLS Therapeutics to Participate in Virtual Non-Deal Roadshow on June 10, 2021

June 9, 2021

HLS Therapeutics Announces Participation at Upcoming Investor Conferences

May 26, 2021

HLS Therapeutics Announces First Quarter Fiscal 2021 Financial Results

May 6, 2021

HLS Therapeutics to Host Q1 2021 Financial Results Conference Call

April 22, 2021

HLS Therapeutics Announces Participation in Upcoming Conferences

April 15, 2021

HLS Therapeutics Comments on Rule Enacted by Quebec Health Minister Christian Dubé and the Absence of an Exception for New Refractory Schizophrenic Patients

April 1, 2021

← Newer news releases · Older news releases →

Calls

The 5 newest of 7 calls. Every call is listed under its year.

Decks

The 5 newest of 28 decks. Every deck is listed under its year.